CFDE Data Portal | Search PBX2

	Label	Description
	PBX2 Gene (Entity type)	ENSG00000204304 - PBX homeobox 2
	PBX2 associations Collection (Entity type)	Associations for PBX2_associations
	PBX2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PBX2 MOUSE Protein (Entity type)	Pre-B-cell leukemia transcription factor 2
	PBX2 HUMAN Protein (Entity type)	Pre-B-cell leukemia transcription factor 2
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE96649 1 V 0 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 2 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212231 GSE218491 SHP2 inhibition 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

PBX2

ENSG00000204304 - PBX homeobox 2

PBX2 associations

Associations for PBX2_associations

PBX2 associations.tsv

A file from IDG as part of the Harmonizome project

PBX2 MOUSE

Pre-B-cell leukemia transcription factor 2

PBX2 HUMAN

Pre-B-cell leukemia transcription factor 2

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE96649 1 V 0 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 2 v 7 human up

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 7 human dn

A Gene Set from LINCS

GSE212231 GSE218491 SHP2 inhibition 3 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.